Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

1-Methylxanthine derived from caffeine as a pharmacodynamic probe of oxypurinol effect.

Birkett DJ, Miners JO, Valente L, Lillywhite KJ, Day RO.

Br J Clin Pharmacol. 1997 Feb;43(2):197-200.

2.

Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drug.

Miners JO, Valente L, Lillywhite KJ, Mackenzie PI, Burchell B, Baguley BC, Kestell P.

Cancer Res. 1997 Jan 15;57(2):284-9.

3.

cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.

Jin CJ, Miners JO, Lillywhite KJ, Mackenzie PI.

Biochem Biophys Res Commun. 1993 Jul 15;194(1):496-503.

PMID:
8333863
4.
5.
6.

Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes.

Miners JO, Lillywhite KJ, Yoovathaworn K, Pongmarutai M, Birkett DJ.

Biochem Pharmacol. 1990 Aug 1;40(3):595-600.

PMID:
2116803
7.
8.

Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes.

Miners JO, Lillywhite KJ, Matthews AP, Jones ME, Birkett DJ.

Biochem Pharmacol. 1988 Feb 15;37(4):665-71.

PMID:
3124857
9.

Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man.

Miners JO, Wing LM, Lillywhite KJ, Robson RA.

Br J Clin Pharmacol. 1985 Sep;20(3):219-23.

10.

The effect of ranitidine on the disposition of lignocaine.

Robson RA, Wing LM, Miners JO, Lillywhite KJ, Birkett DJ.

Br J Clin Pharmacol. 1985 Aug;20(2):170-3.

11.

Verapamil disposition--effects of sulphinpyrazone and cimetidine.

Wing LM, Miners JO, Lillywhite KJ.

Br J Clin Pharmacol. 1985 Mar;19(3):385-91.

12.

Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.

Miners JO, Wing LM, Lillywhite KJ, Smith KJ.

Br J Clin Pharmacol. 1984 Dec;18(6):853-60.

Supplemental Content

Loading ...
Support Center